Business
Syntopix completes microemulsions challenge
Syntopix completes microemulsions challenge.
About this update from Gunsynd Plc
[{"type":"text","content":"\n \nRNS Number : 8445H Syntopix Group plc 06 June 2011 \n \n\n \n\n\n\n\nPress Release\n\n\n06 June 2011\n\n\n\n\n \nSyntopix Group plc\n(\"Syntopix\" or \"The Group\")\n \nSyntopix completes challenge to develop new microemulsions for healthcare products\n \nSyntopix Group plc (AIM: SYN), the antimicrobial research company, is pleased to announce it has completed the international research challenge into formulation design for healthcare and cosmetic products, announced in December. As a result of this project, backed by Intelligent Formulation Ltd, Syntopix has identified two 'green' surfactants to incorporate into novel oral care microemulsions.\n \nSyntopix, along with international chemistry experts, investigated how to rationally design cosmetic and personal care formulations containing novel surfactants. Used to create emulsions and microemulsions, surfactants help the water and 'oil' components to hold together in stable formulations. The project focussed on surfactants to satisfy the growing consumer demand for natural, environmentally friendly and biodegradable ingredients that are used to formulate cosmetic products. \n \nThe team were successful in measuring a characteristic known as the \"Cc\" (characteristic curvature) for a range of green surfactants with different properties. The Cc value gives information about how useful the surfactants will be in forming microemulsions and using measured Cc values makes it much easier to identify which surfactants are likely to match well to typical oils and formulation conditions. Specialist computer software can then help scientists to adjust and improve the formulations. The combined approach saves time, money and resource in the development of formulations. \n \nSyntopix has placed all Cc values from the project in the public domain and it is hoped the resultant data will assist scientists to formulate new cosmetic, pharmaceutical and personal care products. \n \nDr. Steve Jones, CEO of Syntopix Group plc said: \"The work Syntopix has done to characterise surfactants is a benefit not only to the Group but also to the wider scientific community. The project will help define the parameters for successful formulations and we hope that it will encourage surfactant suppliers to measure and provide Cc values to aid their...